Benmoxin

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Benmoxin
Benmoxin.svg
Systematic (IUPAC) name
N'-(1-phenylethyl)benzohydrazide
Clinical data
Legal status
  • ℞ (Prescription only)
Routes of
administration
Oral
Identifiers
CAS Number 7654-03-7 N
ATC code None
PubChem CID: 71671
ChemSpider 64728 YesY
UNII XC9FY2SGBG YesY
ChEMBL CHEMBL1877495 N
Chemical data
Formula C15H16N2O
Molecular mass 240.30 g/mol
 NYesY (what is this?)  (verify)

Benmoxin (trade names Neuralex, Nerusil), also known as mebamoxine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class.[1][2] It was synthesized in 1967 and was subsequently used as an antidepressant in Europe, but is now no longer marketed.[1][2]

See also

References

  1. 1.0 1.1 Ganellin, C. R.; Triggle, David J. (1996). Dictionary of Pharmacological Agents, Volumes 1-2. Chapman & Hall. p. 229. ISBN 0-9630096-0-5.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>
  2. 2.0 2.1 Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 3-88763-075-0.<templatestyles src="Module:Citation/CS1/styles.css"></templatestyles>